Lista de obras -

Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2

artículo científico publicado en 2006

Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact.

artículo científico publicado en 2005

An RGS4-mediated phenotypic switch of bronchial smooth muscle cells promotes fixed airway obstruction in asthma

artículo científico publicado en 2012

Assays for in vitro monitoring of human airway smooth muscle (ASM) and human pulmonary arterial vascular smooth muscle (VSM) cell migration

artículo científico publicado en 2006

Cross-talk between tuberin, calmodulin, and estrogen signaling pathways

artículo científico publicado en 2005

Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration

artículo científico publicado en 2003

DHEA-S inhibits human neutrophil and human airway smooth muscle migration

artículo científico publicado en 2012

Differential effects of formoterol on thrombin- and PDGF-induced proliferation of human pulmonary arterial vascular smooth muscle cells

artículo científico publicado en 2012

Doxycycline reduces the migration of tuberous sclerosis complex-2 null cells - effects on RhoA-GTPase and focal adhesion kinase

artículo científico publicado en 2015

Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK.

artículo científico publicado en 2014

Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion

artículo científico publicado en 2012

Idiopathic multicentric Castleman's disease: a systematic literature review

artículo científico publicado en 2016

Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation

artículo científico publicado en 2007

Interferons modulate mitogen-induced protein synthesis in airway smooth muscle

artículo científico publicado en 2010

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease

artículo científico publicado en 2017

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

artículo científico publicado en 2018

Lymphangioleiomyomatosis: A Monogenic Model of Malignancy

artículo científico publicado en 2017

Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension

artículo científico publicado en 2013

Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis

scientific article published on 30 December 2005

PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects

artículo científico publicado en 2009

Pharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosis

artículo científico publicado en 2015

Phosphatidylinositol 3-kinase but not tuberin is required for PDGF-induced cell migration

artículo científico publicado en 2002

Phosphodiesterases regulate airway smooth muscle function in health and disease

artículo científico publicado en 2007

Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM)

artículo científico publicado en 2012

Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges

artículo científico publicado en 2008

Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder

artículo científico publicado en 2013

Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells.

artículo científico publicado en 2018

Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis.

scientific article published on 13 July 2009

Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis

artículo científico publicado en 2008

Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling

artículo científico publicado en 2013

Surfactant dysfunction and lung inflammation in the female mouse model of lymphangioleiomyomatosis

artículo científico publicado en 2015

TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase

scientific journal article

TSC2 modulates cell adhesion and migration via integrin-α1β1

artículo científico publicado en 2012

Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM)

artículo científico publicado en 2012

Targeting the phosphatidylinositol 3-kinase pathway in airway smooth muscle: rationale and promise

artículo científico publicado en 2007

The PP2A-associated protein alpha4 plays a critical role in the regulation of cell spreading and migration

artículo científico publicado en 2007

Therapeutic Strategies for Treatment of Pulmonary Lymphangioleiomyomatosis (LAM)

artículo científico publicado en 2014

Treatment option(s) for pulmonary lymphangioleiomyomatosis: progress and current challenges

artículo científico publicado en 2012

Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)

scientific journal article

Tumor suppressors TSC1 and TSC2 differentially modulate actin cytoskeleton and motility of mouse embryonic fibroblasts

artículo científico publicado en 2014

Tumour suppressors hamartin and tuberin: intracellular signalling

artículo científico publicado en 2003

Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.

artículo científico publicado en 2017

Wild type mesenchymal cells contribute to the lung pathology of lymphangioleiomyomatosis

artículo científico publicado en 2015

mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia ⬇️

artículo científico publicado el 2 de marzo de 2011

mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline

artículo científico publicado en 2020

mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells ⬇️

artículo científico publicado el 11 de abril de 2011

β2-Adrenergic Receptor Agonists Modulate Human Airway Smooth Muscle Cell Migration via Vasodilator-Stimulated Phosphoprotein ⬇️

artículo científico publicado el 1 de enero de 2012

Lista de obras de

Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2

Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact.

An RGS4-mediated phenotypic switch of bronchial smooth muscle cells promotes fixed airway obstruction in asthma

Assays for in vitro monitoring of human airway smooth muscle (ASM) and human pulmonary arterial vascular smooth muscle (VSM) cell migration

Cross-talk between tuberin, calmodulin, and estrogen signaling pathways

Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration

DHEA-S inhibits human neutrophil and human airway smooth muscle migration

Differential effects of formoterol on thrombin- and PDGF-induced proliferation of human pulmonary arterial vascular smooth muscle cells

Doxycycline reduces the migration of tuberous sclerosis complex-2 null cells - effects on RhoA-GTPase and focal adhesion kinase

Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK.

Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion

Idiopathic multicentric Castleman's disease: a systematic literature review

Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation

Interferons modulate mitogen-induced protein synthesis in airway smooth muscle

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Lymphangioleiomyomatosis: A Monogenic Model of Malignancy

Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension

Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis

PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects

Pharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosis

Phosphatidylinositol 3-kinase but not tuberin is required for PDGF-induced cell migration

Phosphodiesterases regulate airway smooth muscle function in health and disease

Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM)

Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges

Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder

Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells.

Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis.

Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis

Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling

Surfactant dysfunction and lung inflammation in the female mouse model of lymphangioleiomyomatosis

TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase

TSC2 modulates cell adhesion and migration via integrin-α1β1

Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM)

Targeting the phosphatidylinositol 3-kinase pathway in airway smooth muscle: rationale and promise

The PP2A-associated protein alpha4 plays a critical role in the regulation of cell spreading and migration

Therapeutic Strategies for Treatment of Pulmonary Lymphangioleiomyomatosis (LAM)

Treatment option(s) for pulmonary lymphangioleiomyomatosis: progress and current challenges

Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)

Tumor suppressors TSC1 and TSC2 differentially modulate actin cytoskeleton and motility of mouse embryonic fibroblasts

Tumour suppressors hamartin and tuberin: intracellular signalling

Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.

Wild type mesenchymal cells contribute to the lung pathology of lymphangioleiomyomatosis

mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia ⬇️

mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline

mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells ⬇️

β2-Adrenergic Receptor Agonists Modulate Human Airway Smooth Muscle Cell Migration via Vasodilator-Stimulated Phosphoprotein ⬇️